Angiogenesis in wounds treated by microdeformational wound therapy

Annals of Surgery

Volumn 253, Issue 2, 2011, Pages 402-409

  Erba, Paolo ^a,b   Ogawa, Rei ^a,c   Ackermann, Maximilian ^d   Adini, Avner ^f   Miele, Lino F ^e   Dastouri, Pouya ^a   Helm, Doug ^a   Mentzer, Steven J ^e   D'Amato, Robert J ^f   Murphy, George F ^a   Konerding, Moritz A ^d   Orgill, Dennis P ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c NIPPON MEDICAL SCHOOL   (Japan)

^d JOHANNES GUTENBERG UNIVERSITY   (Germany)

^e BOSTON CHILDREN S HOSPITAL   (United States)

^f Department of Surgery   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD31 ANTIGEN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA; PIMONIDAZOLE; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HYPOXIA; IMMUNOHISTOCHEMISTRY; MALE; MORPHOMETRICS; MOUSE; NONHUMAN; OCCLUSIVE DRESSING; OXYGENATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VACUUM ASSISTED CLOSURE; WESTERN BLOTTING; WOUND DRESSING; WOUND HEALING;

ANIMALS; ANTIGENS, CD31; BIOMECHANICS; GRANULATION TISSUE; MALE; MICE; MICE, INBRED C57BL; MICROVESSELS; NEGATIVE-PRESSURE WOUND THERAPY; NEOVASCULARIZATION, PHYSIOLOGIC; OCCLUSIVE DRESSINGS; OXYGEN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SKIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A; WOUND HEALING;

EID: 79151474594     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e31820563a8     Document Type: Article

References (61)

1. Brem H, Tomic-Canic M. Cellular and molecular basis of wound healing in diabetes. J Clin Invest. 2007;117(5):1219-12122.
2. Pugh CW, Ratcliffe PJ. Regulation of angiogenesis by hypoxia: role of the HIF system. Nat Med. 2003;9(6):677-684.
3. Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med. 2003;9(6):669-676.
4. Greenberg JI, Shields DJ, Barillas SG, et al.Arole forVEGF as a negative regulator of pericyte function and vesselmaturation. Nature. 2008;456(7223):809-813.
5. Willett CG, Boucher Y, di Tomaso E, et al. Direct evidence that the VEGFspecific antibody bevacizumab has antivascular effects in human rectal cancer. Nat Med. 2004;10(2):145-147.
6. Stockmann C, Doedens A, Weidemann A, et al. Deletion of vascular endothelial growth factor in myeloid cells accelerates tumorigenesis. Nature. 2008;456(7223):814-818.
7. Jinnin M, Medici D, Park L, et al. Suppressed NFAT-dependent VEGFR1 expression and constitutive VEGFR2 signaling in infantile hemangioma. Nat Med. 2008;14(11):1236-1246.
8. Arany Z, Foo SY, Ma Y, et al. HIF-independent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1alpha. Nature. 2008;451(7181):1008-1012.
9. Sessa C, Guibal A, Del Conte G, et al. Biomarkers of angiogenesis for the development of antiangiogenic therapies in oncology: tools or decorations? Nat Clin Pract Oncol. 2008;5(7):378-391.
10. Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature. 2000;407(6801):249-257.
11. Zhou J, Schmid T, Schnitzer S, et al. Tumor hypoxia and cancer progression. Cancer Lett. 2006;237(1):10-21.
12. Takahashi Y, Takahashi S, Shiga Y, et al. Hypoxic induction of prolyl 4-hydroxylase alpha (I) in cultured cells. J Biol Chem. 2000;275(19):14139- 14146.
13. O'Toole EA, Marinkovich MP, Peavey CL, et al. Hypoxia increases human keratinocyte motility on connective tissue. J Clin Invest. 1997;100(11): 2881-2891.
14. Mantovani A, Allavena P, Sica A, et al. Cancer-related inflammation. Nature. 2008;454(7203):436-444.
15. Naumov GN, Folkman J, Straume O. Tumor dormancy due to failure of angiogenesis: role of the microenvironment. Clin Exp Metastasis. 2009;26(1): 51-60.
16. Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420(6917): 860-867.
17. Elson DA, Ryan HE, Snow JW, et al. Coordinate up-regulation of hypoxia inducible factor (HIF)-1alpha and HIF-1 target genes during multistage epidermal carcinogenesis and wound healing. Cancer Res. 2000;60(21): 6189-6195.
18. Kodelja V, Muller C, Tenorio S, et al. Differences in angiogenic potential of classically vs alternatively activated macrophages. Immunobiology. 1997;197(5):478-493.
19. Sen CK, Khanna S, Babior BM, et al. Oxidant-induced vascular endothelial growth factor expression in human keratinocytes and cutaneouswound healing. J Biol Chem. 2002;277(36):33284-33290.
20. Nissen NN, Polverini PJ, Koch AE, et al. Vascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healing. Am J Pathol. 1998;152(6):1445-1452.
21. Constant JS, Feng JJ, Zabel DD, et al. Lactate elicits vascular endothelial growth factor from macrophages: a possible alternative to hypoxia. Wound Repair Regen. 2000;8(5):353-360.
22. Folkman J. Angiogenesis: an organizing principle for drug discovery? Nat Rev Drug Discov. 2007;6(4):273-286.
23. Haroon ZA, Raleigh JA, Greenberg CS, et al. Early wound healing exhibits cytokine surge without evidence of hypoxia. Ann Surg. 2000;231(1): 137-147.
24. Murdoch C, Giannoudis A, Lewis CE.Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues. Blood. 2004;104(8):2224-2234.
25. Knighton DR, Hunt TK, Scheuenstuhl H, et al. Oxygen tension regulates the expression of angiogenesis factor by macrophages. Science. 1983;221(4617):1283- 1285.
26. Huang LE, Gu J, Schau M, et al. Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway. Proc Natl Acad Sci USA. 1998;95(14): 7987-7892.
27. Fong GH. Regulation of angiogenesis by oxygen sensing mechanisms. J Mol Med. 2009;87(6):549-560.
28. Oberringer M, Meins C, Bubel M, et al. In vitro wounding: effects of hypoxia and transforming growth factor beta1 on proliferation, migration and myofi- broblastic differentiation in an endothelial cell-fibroblast co-culture model. J Mol Histol. 2008;39(1):37-47.
29. Gordillo GM, Sen CK.Revisiting the essential role of oxygen inwound healing. Am J Surg. 2003;186(3):259-263.
30. Mathieu D. Hyperbaric oxygen therapy in the management of non-healing wounds. In: Bakker DJ, Cramer FS, eds. Hyperbaric surgery. Flagstaff, AZ: Best Publishing Company;2002:317-339.
31. Greif R, Akca O, Horn EP, et al. Supplemental perioperative oxygen to reduce the incidence of surgical-wound infection. Outcomes Research Group. N Engl J Med. 2000;342(3):161-167.
32. Mammoto A, Connor KM, Mammoto T, et al. A mechanosensitive transcriptional mechanism that controls angiogenesis. Nature. 2009;457(7233):1103-1108.
33. Li J, Hampton T, Morgan JP, et al. Stretch-induced VEGF expression in the heart. J Clin Invest. 1997;100(1):18-24.
34. Seko Y, Seko Y, Takahashi N, et al. Pulsatile stretch stimulates vascular endothelial growth factor (VEGF) secretion by cultured rat cardiac myocytes. Biochem Biophys Res Commun. 1999;254(2):462-465.
35. Chang H, Wang BW, Kuan P, et al. Cyclical mechanical stretch enhances angiopoietin-2 and Tie2 receptor expression in cultured human umbilical vein endothelial cells. Clin Sci (Lond). 2003;104(4): 421-428.
36. Cloutier M, Maltais F, Piedboeuf B. Increased distension stimulates distal capillary growth as well as expression of specific angiogenesis genes in fetal mouse lungs. Exp Lung Res. 2008;34(3):101-113.
37. KilarskiWW, Samolov B, Petersson L, et al. Biomechanical regulation of blood vessel growth during tissue vascularization. Nat Med. 2009;15(6):657-664.
38. Greene AK, Puder M, Roy R, et al. Microdeformational wound therapy: effects on angiogenesis and matrix metalloproteinases in chronic wounds of 3 debilitated patients. Ann Plast Surg. 2006;56(4):418-422.
39. Chen SZ, Li J, Li XY, et al. Effects of vacuum-assisted closure on wound microcirculation: an experimental study. Asian J Surg. 2005;28(3):211-217.
40. Labanaris AP, Polykandriotis E, Horch RE. The effect of vacuum-assisted closure on lymph vessels in chronic wounds. J Plast Reconstr Aesthet Surg. 2008;62(8):1068-1075.
41. Grimm A, Dimmler A, Stange S, et al. Expression of HIF-1 alpha in irradiated tissue is altered by topical negative-pressure therapy. Strahlenther Onkol. 2007;183(3):144-149.
42. Labler L, Rancan M, Mica L, et al. Vacuum-assisted closure therapy increases local interleukin-8 and vascular endothelial growth factor levels in traumatic wounds. J Trauma. 2009;66(3):749-757.
43. Fong GH. Mechanisms of adaptive angiogenesis to tissue hypoxia. Angiogenesis. 2008;11(2):121-140.
44. Moues CM, van ToorenenbergenAW,Heule F, et al. The role of topical negative pressure in wound repair: expression of biochemical markers in wound fluid during wound healing. Wound Repair Regen. 2008;16(4):488-494.
45. Ford CN, Reinhard ER, Yeh D, et al. Interim analysis of a prospective, randomized trial of vacuum-assisted closure versus the healthpoint system in the management of pressure ulcers. Ann Plast Surg. 2002;49(1):55-61; discussion 61.
46. Gouttefangeas C, Eberle M, Ruck P, et al. Functional T lymphocytes infiltrate implanted polyvinyl alcohol foams during surgicalwound closure therapy. Clin Exp Immunol. 2001;124(3):398-405.
47. Scherer SS, Pietramaggiori G, Mathews JC, et al. The mechanism of action of the vacuum-assisted closure device. Plast Reconstr Surg. 2008;122(3):786-797.
48. Greenhalgh DG, Sprugel KH, Murray MJ, et al. PDGF and FGF stimulate wound healing in the genetically diabetic mouse. Am J Pathol. 1990;136(6):1235-1246.
49. Yannas IV, Burke JF, Warpehoski M, et al. Prompt, long-term functional replacement of skin. Trans Am Soc Artif Intern Organs. 1981;27:19-23.
50. Weibel ER, Kistler GS, Scherle WF. Practical stereological methods for morphometric cytology. J Cell Biol. 1966;30(1):23-38.
51. Konerding MA, Klapthor B, Bruch J. A simple and accurate method for 3-D measurements in microcorrosion casts illustrated with tumour vascularization. Anal Cell Pathol. 1995;9(1):69-81.
52. Zhong H, Simons JW. Direct comparison of GAPDH, beta-actin, cyclophilin, and 28S rRNAas internal standards for quantifying RNAlevels under hypoxia. Biochem Biophys Res Commun. 1999;259(3):523-526.
53. Fukumura D, Jain RK. Tumor microvasculature and microenvironment: targets for anti-angiogenesis and normalization. Microvasc Res. 2007;74(2-3):72-84.
54. McNulty AK, Schmidt M, Feeley T, et al. Effects of negative pressure wound therapy on fibroblast viability, chemotactic signaling, and proliferation in a provisional wound (fibrin) matrix.Wound Repair Regen. 2007;15(6):838-846.
55. Evans SM, Schrlau AE, Chalian AA, et al. Oxygen levels in normal and previously irradiated human skin as assessed by EF5 binding. J Invest Dermatol. 2006;126(12):2596-25606.
56. Knighton DR, Silver IA, Hunt TK. Regulation of wound-healing angiogenesiseffect of oxygen gradients and inspired oxygen concentration. Surgery. 1981;90(2):262-270.
57. Helm CL, Fleury ME, Zisch AH, et al. Synergy between interstitial flow and VEGF directs capillary morphogenesis in vitro through a gradient amplification mechanism. Proc Natl Acad Sci USA. 2005;102(44): 15779-15784.
58. Gerhardt H, Golding M, Fruttiger M, et al. VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. J Cell Biol. 2003;161(6): 1163-1177.
59. Morbidelli L, Birkenhaeger R, Roeckl W, et al. Distinct capillary density and progression promoted by vascular endothelial growth factor-A homodimers and heterodimers. Angiogenesis. 1997;1(1):117-130.
60. Potgens AJ, Lubsen NH, van Altena MC, et al. Covalent dimerization of vascular permeability factor/vascular endothelial growth factor is essential for its biological activity. Evidence from Cys to Ser mutations. J Biol Chem. 1994;269(52):32879-32885.
61. Petersen W, Varoga D, Zantop T, et al. Cyclic strain influences the expression of the vascular endothelial growth factor (VEGF) and the hypoxia inducible factor 1 alpha (HIF-1alpha) in tendon fibroblasts. J Orthop Res. 2004;22(4): 847-853.